phase 2_completion
saveMayo Clinic — kava (Phase II Trial Completion)
community read0 votes
Therapy area: Central Nervous System. Indication: Unspecified Psychiatric Disorders
Data sources
globaldata
Found something off?
same company · ±60 days · 6
- phase 1 2 initiationeflornithine hydrochloride: Mayo Clinic — eflornithine hydrochloride (Phase I/II Trial Initiation)Apr 24, 2026
- grantMAYO CLINIC ROCHESTER — The Lymphoma Epidemiology of Outcomes (LEO) Cohort StudyApr 1, 2026
- grantMAYO CLINIC ROCHESTER — Molecular mechanisms of sexually dimorphic traits of interstitial cells of Ca...Apr 1, 2026
- grantMAYO CLINIC ROCHESTER — Overcoming Challenging Clinical Scenarios in Non-invasive Coronary Artery Ima...Apr 1, 2026
- grantMAYO CLINIC ROCHESTER — Transforming ANA Testing: Leveraging Epidemiology and AI to Detect Autoimmune...Apr 1, 2026
- grantMAYO CLINIC ROCHESTER — Establishing the etiology of chronic placental villitis of unknown etiologyApr 1, 2026
related news · 4
- statHow AI helped treat a newborn’s ultra rare disease. ‘It was almost like a light switch.’
- statOpinion: Hospitals are silencing doctors online, and it’s fueling the health misinformation crisis
- statOpinion: STAT readers on MAHA activists, perimenopause, and diversity in medical school
- statTrump drops Casey Means as surgeon general nominee, opts for radiologist Nicole Saphier
comments(0)
5-min edit window · permanent after that